44 related articles for article (PubMed ID: 10689270)
1. beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.
Hoit BD; Suresh DP; Craft L; Walsh RA; Liggett SB
Am Heart J; 2000 Mar; 139(3):537-42. PubMed ID: 10689270
[TBL] [Abstract][Full Text] [Related]
2. Variable-length poly-C tract polymorphisms of the beta2-adrenergic receptor 3'-UTR alter expression and agonist regulation.
Panebra A; Schwarb MR; Swift SM; Weiss ST; Bleecker ER; Hawkins GA; Liggett SB
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L190-5. PubMed ID: 18024720
[TBL] [Abstract][Full Text] [Related]
3. Genetic Predictors of Salt Sensitivity of Blood Pressure: The Additive Impact of 2 Hits in the Same Biological Pathway.
Haas AV; En Yee L; Yuan YE; Wong YH; Hopkins PN; Jeunemaitre X; Lasky-Su J; Williams JS; Adler GK; Williams GH
Hypertension; 2021 Dec; 78(6):1809-1817. PubMed ID: 34757767
[TBL] [Abstract][Full Text] [Related]
4. β
Rodrigues JAL; Ferrari GD; Trapé ÁA; de Moraes VN; Gonçalves TCP; Tavares SS; Tjønna AE; de Souza HCD; Júnior CRB
Eur J Appl Physiol; 2020 Mar; 120(3):613-624. PubMed ID: 31915906
[TBL] [Abstract][Full Text] [Related]
5. Low-Level Cumulative Lead and Resistant Hypertension: A Prospective Study of Men Participating in the Veterans Affairs Normative Aging Study.
Zheutlin AR; Hu H; Weisskopf MG; Sparrow D; Vokonas PS; Park SK
J Am Heart Assoc; 2018 Nov; 7(21):e010014. PubMed ID: 30608198
[TBL] [Abstract][Full Text] [Related]
6. Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study.
Chung JE; Choi SA; Hwang HS; Park JY; Lee KE; Yee J; Kim YJ; Gwak HS
BMC Genet; 2017 Nov; 18(1):96. PubMed ID: 29132297
[TBL] [Abstract][Full Text] [Related]
7. Potassium concentration on admission is an independent risk factor for target lesion revascularization in acute myocardial infarction.
Honda T; Fujimoto K; Miyao Y; Koga H; Ishii M
ScientificWorldJournal; 2014; 2014():946803. PubMed ID: 24523655
[TBL] [Abstract][Full Text] [Related]
8. Relationships of adrenoceptor polymorphisms with obesity.
Masuo K; Lambert GW
J Obes; 2011; 2011():609485. PubMed ID: 21603275
[TBL] [Abstract][Full Text] [Related]
9. The genomic architecture of sporadic heart failure.
Dorn GW
Circ Res; 2011 May; 108(10):1270-83. PubMed ID: 21566223
[TBL] [Abstract][Full Text] [Related]
10. Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.
Masuo K
Int J Hypertens; 2010 Oct; 2010():832821. PubMed ID: 20981286
[TBL] [Abstract][Full Text] [Related]
11. beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade.
Hesse C; Schroeder DR; Nicholson WT; Hart EC; Curry TB; Penheiter AR; Turner ST; Joyner MJ; Eisenach JH
J Physiol; 2010 Jul; 588(Pt 14):2669-78. PubMed ID: 20519311
[TBL] [Abstract][Full Text] [Related]
12. {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype.
Eisenach JH; Wittwer ED
Exp Physiol; 2010 Jul; 95(7):757-64. PubMed ID: 20382665
[TBL] [Abstract][Full Text] [Related]
13. GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES.
Hesse C; Eisenach JH
Curr Pharmacogenomics Person Med; 2008 Sep; 6(3):160-170. PubMed ID: 19727431
[TBL] [Abstract][Full Text] [Related]
14. Chronic heart failure: beta-blockers and pharmacogenetics.
Azuma J; Nonen S
Eur J Clin Pharmacol; 2009 Jan; 65(1):3-17. PubMed ID: 18839161
[TBL] [Abstract][Full Text] [Related]
15. Differences in hypertension between blacks and whites: an overview.
Lindhorst J; Alexander N; Blignaut J; Rayner B
Cardiovasc J Afr; 2007; 18(4):241-7. PubMed ID: 17940670
[TBL] [Abstract][Full Text] [Related]
16. In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.
Leineweber K; Bogedain P; Wolf C; Wagner S; Weber M; Jakob HG; Heusch G; Philipp T; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jul; 375(5):303-9. PubMed ID: 17541557
[TBL] [Abstract][Full Text] [Related]
17. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of beta2-agonist drugs in asthma.
Taylor DR
Clin Rev Allergy Immunol; 2006; 31(2-3):247-58. PubMed ID: 17085797
[TBL] [Abstract][Full Text] [Related]
19. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.
Diatchenko L; Anderson AD; Slade GD; Fillingim RB; Shabalina SA; Higgins TJ; Sama S; Belfer I; Goldman D; Max MB; Weir BS; Maixner W
Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):449-62. PubMed ID: 16741943
[TBL] [Abstract][Full Text] [Related]
20. Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans.
Eisenach JH; Schroeder DR; Pike TL; Johnson CP; Schrage WG; Snyder EM; Johnson BD; Garovic VD; Turner ST; Joyner MJ
J Physiol; 2006 Aug; 574(Pt 3):955-65. PubMed ID: 16740612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
